We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

Back to rankings

64 hedge funds and large institutions have $27.5M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 14

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

2% more funds holding

Funds holding: 63 → 64 (+1)

18% less capital invested

Capital invested by funds: $33.7M → $27.5M (-$6.21M)

72% less call options, than puts

Call options by funds: $327K | Put options by funds: $1.15M

Holders
64
Holders Change
+1
Holders Change %
+1.59%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
14
Closed
8
Calls
$327K
Puts
$1.15M
Net Calls
-$826K
Net Calls Change
-$826K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.44M
2
Millennium Management
Millennium Management
New York
+$1.07M
3
Morgan Stanley
Morgan Stanley
New York
+$729K
4
Deutsche Bank
Deutsche Bank
Germany
+$669K
5
GCP
GSA Capital Partners
United Kingdom
+$243K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.52M
2
BFA
BlackRock Fund Advisors
California
-$1.89M
3
Goldman Sachs
Goldman Sachs
New York
-$168K
4
FIM
Freedom Investment Management
Connecticut
-$132K
5
Federated Hermes
Federated Hermes
Pennsylvania
-$127K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$165K – – –
CLOS
27
Compagnie Lombard Odier SCmA
Switzerland
$128K – – –
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$116K – – –
Group One Trading
29
Group One Trading
Illinois
$114K +$56K +10,926 +89%
HK
30
Horizon Kinetics
New York
$103K – – –
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$103K +$6.72K +1,313 +7%
Citigroup
32
Citigroup
New York
$98K -$11.6K -2,270 -10%
PP
33
PDT Partners
New York
$96K +$12.5K +2,438 +14%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$93K – – –
VKH
35
Virtu KCG Holdings
New York
$91K +$41.5K +8,107 +78%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$84K -$4.1K -800 -4%
Bank of America
37
Bank of America
North Carolina
$83K +$19.2K +3,746 +29%
Wells Fargo
38
Wells Fargo
California
$78K – – –
Citadel Advisors
39
Citadel Advisors
Florida
$75K +$78.1K +15,242 New
PP
40
Paloma Partners
Connecticut
$66K +$68.8K +13,438 New
CG
41
Cutler Group
California
$64K +$67.5K +13,186 New
AIM
42
Acrospire Investment Management
Illinois
$62K +$51.3K +10,019 +387%
NFA
43
Nationwide Fund Advisors
Ohio
$61K – – –
CS
44
Credit Suisse
Switzerland
$60K -$1.98K -387 -3%
Public Employees Retirement Association of Colorado
45
Public Employees Retirement Association of Colorado
Colorado
$59K – – –
AIG
46
American International Group
New York
$56K -$154 -30 -0.3%
Barclays
47
Barclays
United Kingdom
$45K +$26.8K +5,228 +126%
BA
48
BlackRock Advisors
Delaware
$43K +$1.51K +295 +3%
SO
49
STRS Ohio
Ohio
$38K – – –
KBC Group
50
KBC Group
Belgium
$33K -$14.1K -2,753 -29%
1
2
3

OSIR Hedge Fund Activity: Q4 2016 in Review

64 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q4 2016, worth a combined $27.5M — down 18% from $33.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new OSIR positions and 8 closed out — a net gain of 3 holders — while 22 added to existing stakes and 14 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.44M. The largest seller was Fidelity Investments, cutting an estimated $8.52M.

  • 64 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q4 2016, up from 63 in Q3 2016.
  • Funds reported $27.5M of Osiris Therapeutics, Inc. Common Stock stock for Q4 2016, down 18% quarter-over-quarter.
  • 11 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q4 2016 and 8 closed out, a net change of +3 holders.
  • The largest Osiris Therapeutics, Inc. Common Stock buyer in Q4 2016 was Renaissance Technologies, an estimated $1.44M added.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q4 2016 was Fidelity Investments, an estimated $8.52M sold.

Based on aggregated 13F filings for Q4 2016.